Orthopediatrics (KIDS) Liabilities and Shareholders Equity (2016 - 2026)

Orthopediatrics' Liabilities and Shareholders Equity history runs 11 years deep, the most recent figure standing at $502.2 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 6.79% year-over-year to $502.2 million; the TTM figure through Mar 2026 stood at $2.0 billion (up 7.75% YoY), while the FY2025 annual figure was $508.6 million, up 7.49% from the prior year.
• Liabilities and Shareholders Equity was $502.2 million for Q1 2026 at Orthopediatrics, down from $508.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $508.6 million in Q4 2025 to a low of $301.0 million in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $443.0 million across 5 years, with a median of $437.2 million in 2024.
• Biggest YoY gain for Liabilities and Shareholders Equity was 41.65% in 2022; the steepest drop was 3.94% in 2022.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $427.7 million in 2022, then increased by 2.58% to $438.7 million in 2023, then climbed by 7.86% to $473.2 million in 2024, then advanced by 7.49% to $508.6 million in 2025, then declined by 1.27% to $502.2 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $502.2 million (Q1 2026), $508.6 million (Q4 2025), and $493.5 million (Q3 2025), per Business Quant data.